site logo

J&J device chief on company split, omicron surge, robotic surgery

Ashley McEvoy is confident 2022 will not be as bad as the first or second year of the pandemic, even as the omicron variant drives cases up, but adds "we're not out of the woods yet."

Permission granted by Johnson & Johnson